Investigating ubiquitination-regulated cell cycle events underpinning malaria transmission

研究泛素化调节的细胞周期事件支撑疟疾传播

基本信息

  • 批准号:
    MR/Y013174/1
  • 负责人:
  • 金额:
    $ 85.27万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2024
  • 资助国家:
    英国
  • 起止时间:
    2024 至 无数据
  • 项目状态:
    未结题

项目摘要

Malaria is caused by the unicellular pathogen Plasmodium that threatens around 400 million people globally and results in over 0.5 million deaths annually, thereby continuing to be a major public health problem, and urgently requiring new therapeutics. Completion of the malaria parasite's complex lifecycle requires a mammalian host where it causes disease, as well as a mosquito vector responsible for spread of the disease. Consequently, effective elimination of malaria will require both curative and transmission blocking strategies. Similar to other eukaryotes, Plasmodium replicates it's genome to divide, proliferate and spread. However, several unusual characteristics of parasite genome replication can be exploited to combat the parasite, especially in stages crucial for parasite transmission. Parasite transmission to the mosquito is initiated by sexual male and female gametocytes. Upon experiencing the mosquito environment, the male gametocyte undergoes three rounds of genome replication (called mitosis) with an incredible speed of 10 minutes to form sperm-like gametes that fuse with the female cell. The fertilised zygote then undergoes further genome replication (called meiosis) to develop into a motile ookinete that is responsible for infecting mosquitoes. So how is mitosis in gametocytes and meiosis in zygotes regulated? We discovered that many proteins in gametocytes and zygotes are dynamically modified by the small protein, ubiquitin. Ubiquitin is reversibly attached to proteins to modulate their fate, including their stability, cellular localisation and level of activity, suggesting these reversible marks could play a key role during parasite genome replication. Importantly, an eraser of ubiquitin marks, Plasmodium USP7 (ubiquitin specific protease 7) is crucial for the parasite to complete both mitosis and meiosis. Since it is not experimentally possible to study meiosis in the human malaria parasite (P. falciparum), we will exploit the highly conserved rodent malaria model (P. berghei), to examine how USP7 regulates genome replication both during mitosis and meiosis. In this proposal we will uncover how USP7 prepares the parasite for initiation of DNA replication during transmission stages. Using state-of-the-art proteomics and microscopy techniques, we will identify partners and responders of USP7 and also determine how the enzyme activity and structure of parasite USP7 is divergent from its host's equivalent. Our findings will be influential in establishing platforms to screen for pharmacological USP7 inhibitors. Moreover, identifying how USP7 orchestrates both mitosis and meiosis will be useful in the development of improved therapeutic strategies that target and block multiple steps in parasite transmission.
疟疾是由单细胞病原体疟原虫引起的,该疟原虫在全球范围内威胁着约4亿人,每年导致超过50万人死亡,从而继续存在一个重大的公共卫生问题,并且紧急需要新的治疗剂。疟疾寄生虫复杂生命周期的完成需要引起疾病的哺乳动物宿主,以及负责疾病传播的蚊子载体。因此,有效消除疟疾将需要治愈和传输阻塞策略。与其他真核生物类似,疟原虫复制了其分裂,增殖和扩散的基因组。但是,可以利用寄生虫基因组复制的几种异常特征来对抗寄生虫,尤其是在寄生虫传播至关重要的阶段。寄生虫向蚊子传播是由性男性和女性配子细胞引发的。在经历了蚊子环境后,雄性配子细胞经历了三轮基因组复制(称为有丝分裂),其速度令人难以置信10分钟,以形成与雌性细胞融合的精子样配子。然后,受精的合子经历了进一步的基因组复制(称为减数分裂),形成了一种莫克尼特,该运动负责感染蚊子。那么,合子中的配子细胞和减数分裂的有丝分裂如何受到调节?我们发现,小型蛋白质泛素会动态地修饰配子细胞和合子中的许多蛋白质。泛素可逆地附着在蛋白质上,以调节其命运,包括它们的稳定性,细胞定位和活性水平,表明这些可逆标记在寄生虫基因组复制过程中可能起关键作用。重要的是,泛素标记的橡皮擦,疟原虫USP7(泛素特异性蛋白酶7)对于寄生虫完成有丝分裂和减数分裂至关重要。由于在实验上不可能研究人类疟原虫(恶性疟原虫)中的减数分裂,因此我们将利用高度保守的啮齿动物疟疾模型(P. berghei),以检查USP7如何调节有丝分裂和减数分裂过程中的基因组复制。在此提案中,我们将发现USP7如何准备在传输阶段开始DNA复制的寄生虫。使用最先进的蛋白质组学和显微镜技术,我们将确定USP7的合作伙伴和响应者,并确定寄生虫USP7的酶活性和结构与宿主的等效物的不同。我们的发现将在建立平台以筛选药理学USP7抑制剂方面具有影响力。此外,确定USP7如何编排有丝分裂和减数分裂将有助于发展改进的治疗策略,这些治疗策略针对寄生虫传播中的多个步骤。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Nisha Philip其他文献

Nisha Philip的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似国自然基金

USP13去泛素化SIRT6抑制晶状体上皮细胞氧化应激的分子机制研究
  • 批准号:
    82301192
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
肿瘤来源外泌体circDOCK11靶向树突状细胞易化TRIM13对STING1的泛素化降解诱导肺癌免疫耐受研究
  • 批准号:
    82360505
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
circRIMS2调控GluN2B泛素化降解参与阿尔茨海默病早期突触障碍的机制研究
  • 批准号:
    82372337
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
葡萄VvPUB20泛素化降解VvMYB5b参与干旱胁迫下花色苷积累的分子机制
  • 批准号:
    32372645
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
NLRC3与HSP90结合调控KLF4泛素化在血管内膜新生中的作用及机制研究
  • 批准号:
    82300483
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Elucidation of transcriptional dynamics regulated by poly-ubiquitination activity of PRC1
阐明 PRC1 多泛素化活性调节的转录动力学
  • 批准号:
    23K05736
  • 财政年份:
    2023
  • 资助金额:
    $ 85.27万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Regulation of the ERK signaling pathway by K63-linked polyubiquitination
K63 连接的多聚泛素化对 ERK 信号通路的调节
  • 批准号:
    10701811
  • 财政年份:
    2022
  • 资助金额:
    $ 85.27万
  • 项目类别:
Regulation of the ERK signaling pathway by K63-linked polyubiquitination
K63 连接的多聚泛素化对 ERK 信号通路的调节
  • 批准号:
    10535249
  • 财政年份:
    2022
  • 资助金额:
    $ 85.27万
  • 项目类别:
E2F family transcription factors are directly regulated by TRIM28 to promote castration-resistance in prostate cancer
E2F家族转录因子受TRIM28直接调节促进前列腺癌去势抵抗
  • 批准号:
    10445046
  • 财政年份:
    2021
  • 资助金额:
    $ 85.27万
  • 项目类别:
E2F family transcription factors are directly regulated by TRIM28 to promote castration-resistance in prostate cancer
E2F家族转录因子受TRIM28直接调节促进前列腺癌去势抵抗
  • 批准号:
    10290070
  • 财政年份:
    2021
  • 资助金额:
    $ 85.27万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了